Antiplasmodial Efficacy of Crude Cocoa Powder Extract on CD4+ T-Cell Counts of Plasmodium berghei Infected BALB/c Mice


Background: Drug resistance in malaria warrants the need for alternative therapy from plant food nutrients. The search for novel anti-malarial control spurred a great interest in cocoa which has been portrayed as immune booster against malaria. This study was geared towards estimation of CD4+ cells of P. berghei infected mice treated with cocoa powder extract (CPE) to provide substantive scientific evidence to authenticate the anecdotal report. Methods: Brine shrimp toxicity assay was done to determine LC50 of crude cocoa powder extract. The mice were infected with 1 × 107 of ANKA and NK65 strains of Plasmodium berghei intraperitoneally, while graded doses of the extract were administered by an intra-gastric intubation based on the body weight of mice. Blood samples were analyzed for microscopy and flow cytometry for CD4+ cell counts. Results: The onset of infection was delayed in the group treated before inoculations on day 3 and the level of P. berghei parasitemia was positively associated with induction of CD4+ cells while the negative control group that received normal saline had progressive increase of parasitemia. The mean survival time could not go beyond day14 in ANKA, though both strains responded to CPE in a similar way with chloroquine as a positive control. The CD4+ cells counted increased in both strains treated before and during inoculations and the episodes of malaria was suppressed compared with the control. Conclusion: This study has demonstrated that the antiplasmodial activity of CPE was associated with the level of CD4+ T-cells proliferation which initiated the protective immune response. This therefore calls for efforts to ensure adequate intake of cocoa powder to boost immunity against malaria.

Share and Cite:

O. Aladesemipe, B. Solomon, O. Ibrahim and O. Afolabi, "Antiplasmodial Efficacy of Crude Cocoa Powder Extract on CD4+ T-Cell Counts of Plasmodium berghei Infected BALB/c Mice," Open Journal of Medical Microbiology, Vol. 3 No. 3, 2013, pp. 178-184. doi: 10.4236/ojmm.2013.33027.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] H. O. Edeaga, D. E. Okwu and B. O. Mbaebie, “Phytochemical Constituents of Some Nigerian Medicinal Plants,” African Journal of Biotechnology, Vol. 4, No. 7, 2005, pp. 685-688.
[2] Federal Ministry of Health, “Report of Malaria Situation Analysis Survey Conducted in the Six Zones of Nigeria,” FMOH, Abuja, 2000.
[3] L. M. Barat and P. B. Bloland, “Drug Resistance among Malaria and Other Parasites,” Infectious Diseases Clinics of North America, Vol. 11, 1997, pp. 969-987. doi:10.1016/S0891-5520(05)70400-1
[4] L. Gu, S. E. House, X. Wu, R. L. Prior, “Procyanidin and Catechin Contents and Antioxidant Capacity of Cocoa and Chocolate Products,” Journal of Agricultural and Food Chemistry, Vol. 54, No. 11, 2006, pp. 4057-4061. doi:10.1021/jf060360r
[5] R. Holt, S. Lazarus, M. Sullards, Q. Zhu, D. Schramm and J. Hammerstonne, “Procyanidin Dimer B2 [Epica-Techin] in Human Plasma after the Consumption of Flavanol-Rich Cocoa,” The American Journal of Clinical Nutrition, Vol. 76, No. 4, 2002, pp. 798-804.
[6] K. Kiseko, M. Hiroyuki, F. Syun-ichi, K. Tomotaka and M. Seiji, “Antimalarial Activity of Leaf-Extract of Hyrangea Macrophyla, a Common Japanese Plant,” Acta Medica Okayama, Vol. 54, No. 5, 2000, pp. 227-232.
[7] N. Murakami, “Exploration for New Functions of Poly- phenol Food Additives and Investigation on Structures and Safety of Their Metabolites,” The Japan Food Chemical Research Foundation Research Reports No. 9, 2003.
[8] H. Noedi, Y. Se, K. Schaecher, B. L. Smith, D. Socheat and M. M. Fukuda, “Evidence of Artemisinin-Resistant Malaria in Western Cambodia,” The New England Journal of Medicine, Vol. 359, No. 24, 2008, pp. 2619-2620. doi:10.1056/NEJMc0805011
[9] R. Jambou, E. Legrand, M Niang, N. Khim, P. Lim, B. Volney, M. T. Ekala, C. Bouchier, P. Esterre, T. Fandeur and O. Mercereau-Puijalon, “Resistant Plasmodium falciparum Field Isolates to in Vitro Artemether and Pointmutations of the SERCA PfATPase 6,” Lancet, Vol. 366, No. 9501, 2005, pp. 1960-1963. doi:10.1016/S0140-6736(05)67787-2
[10] J. L. McLaughlin, “Methods,” Journal of Plant Biochemistry & Physiology, Vol. 6, 1991, pp. 1-32.
[11] K. Neukam, W. Stahl, H. Tronnier, H. Sies and U. Heinric, “Consumption of Flavanol-Rich Cocoa Acutely Increases Microcirculation in Human Skin,” European Journal of Nutrition, Vol. 46, No. 1, 2007, pp. 53-56. doi:10.1007/s00394-006-0627-6
[12] D. J. Finney, “Probit Analysis,” 3rd Edition, Cambridge University Press, Cambridge, 1971.
[13] I. Amin, B. K. Koh and R. Asmah, “Effect of Cacao Liquor Extract on Tumor Marker Enzymes during Chemical Hepatocarcinogenesis in Rats,” Journal of Medicinal Food, Vol. 7, No. 1, 2004, pp. 7-12. doi:10.1089/109662004322984635
[14] E. Legrand, B. Volney, J. B. Meynard, P. Esterre and O. Mercereau-Puijalon, “Resistance to Dihydroartemisinin,” Emerging Infectious Diseases, Vol. 13, No. 5, 2007, pp. 808-809. doi:10.3201/eid1305.061442
[15] E. Badell, C. Oeuvrary, A. Moreno, S. Soe, N. Van Rooijen and P. Druilhe, “Human Malaria in Immunocompromised Mice: An in Vivo Model to Study Defense Mechanisms against Plasmodium falciparum,” Journal of Experimental Medicina Sciences, Vol. 192, No. 11, 2000, pp. 1653-1660. doi:10.1084/jem.192.11.1653
[16] M. Menegon, A. A. Talha, C. Sevenni, S. M. Elbushra, A. A. Moamedani, E. M. Malik, T. A. Mohammed, W. H. Wernzdorfer, G. Majori and B. Y. Nour, “Frequency Distribution of Antimalaria Drug Resistant Alleles among Plasmodium falciparum Isolates from Gezira State, Central Sudan, and Gedarif State, Eastern Sudan,” The American Journal of Tropical Medicine and Hygiene, Vol. 83, No. 2, 2010, pp. 250-257. doi:10.4269/ajtmh.2010.09-0514
[17] G. I. Hassan, U. Gregory and H. Maryam, “Serum Ascorbic Acid Concentration in Patients with Acute falciparum Malaria Infection: Possible Significance,” Brazilian Journal of Infectious Diseases, Vol. 8, No. 5, 2004, pp. 378-381.
[18] R. Stephens and J. Langhorne, “Priming of CD4+ T Cells and Development of CD4+T Cell Memory; Lessons for Malaria,” Parasite Immunology, Vol. 28, No. 1-2, 2006, pp. 25-30. doi:10.1111/j.1365-3024.2006.00767.x
[19] J. B. Harborne, “Phytochemical Methods: A Guide to Modern Techniques of Plant Analysis,” 3rd Edition, Chapman and Hall, London, 1998.
[20] T. K. Mao, “Effect of Cocoa Flavanols and Their Related Oligomers on the Secretion of Interleukin-5 in Peripheral Blood Mononuclear Cells,” Journal of Medicinal Food, Vol. 5, No. 1, 2002, pp. 17-22. doi:10.1089/109662002753723188
[21] A. Metzger, G. Mukasa, A. H. Shankar, G. Ndeezi, G. Melikian and R. D. Semba, “Antioxidant Status and Acute Malaria in Children in Kampala, Uganda,” The American Journal of Tropical Medicine and Hygiene, Vol. 65, No. 2, 2001, pp. 115-119.
[22] D. J. Weatherall, S. Abdalla and M. J. Pippard, “The Anaemia of Plasmodium falciparum Malaria,” Ciba Foundation Symposium, Vol. 94, 1983, pp. 74-97.
[23] E. Nardin, F. Zavala, V. Nussenzweig and R. S. Nussenweig, “Pre-Erythrocytic Malaria Vaccine; Mechanisms of Protective Immunity and Human Vaccine Trials,” Parassitologia, Vol. 41, No. 1-3, 1999, pp. 439-402.
[24] B. C. Urban and N. M. Stevenson, “Early Interactions between Blood-Stage Plasmodium Parasites and the Immune System,” Current Topics in Microbiology and Immunology, Vol. 297, 2005, pp. 25-70. doi:10.1007/3-540-29967-X_2
[25] Q. Y. Zhu, D. D. Schramm, H. B. Gross, R. R. Holt, S. H. Kim and T. Yamaguchi, “Influence of Cocoa Flavanols and Procyandins on Free Radical-Induced Human Erythrocyte Hemolysis,” Clinical and Developmental Immunology, Vol. 12, No. 1, 2005, pp. 27-34. doi:10.1080/17402520512331329514
[26] B. N. Meyer, N. R. Ferrigni, J. E. Putman, L. B. Jacobson, D. E. Nichols and J. L. McLaughlin, “In Vivo Lethality in BST Assay,” Planta Medica, Vol. 45, No. 5, 1982, pp. 31-34. doi:10.1055/s-2007-971236
[27] C. Guinovart, M. M. Navia, M. Tanner and P. L. Alonso, “Malaria: Burden of Disease,” Current Molecular Medicine, Vol. 6, No. 2, 2006, pp. 137-140. doi:10.2174/156652406776055131
[28] D. Dawit, M. Eyassu, D. Asfaw, A. Dawit, U. Kelbessa, M. Wallenlign, M. A. Daniel, M. Yared, “In Vivo Antimalarial Activity of Hydroalcoholic Extracts from Asparagus africanus Lam. In Mice Infected with Plasmodium berghei,” Ethiopian Journal of Health Development, Vol. 2, 2006, pp. 112-118.
[29] J. Langhorne, “The Role of CD4+ T-Cells in the Immune Response to Plasmodium chabaudi,” Parasitology Today, Vol. 5, 1989, pp. 362-364. doi:10.1016/0169-4758(89)90113-0
[30] R. Ramasamy, “Molecular Basis for Evasion of Host Immunity and Pathogenesis in Malaria,” Biochimica et Biophysica Acta, Vol. 1406, No. 1, 1998, pp. 10-27. doi:10.1016/S0925-4439(97)00078-1
[31] A. F. David, J. R. Phillip, L. C. Simon, B. Reto and N. Solomon, “The Antimalarial Drug Discovery: Efficacy Models for Compound Screening,” Nature Reviews, Vol. 3, No. 6, 2004, pp. 509-520. doi:10.1038/nrd1416
[32] A. Beaute-Lafitte, V. Altemayer-Caillard, F. Gonnet-Gonzalez, L. Ramiaramana, A. G. Chabaud and I. Laudau, “The Chemosensitivity of the Rodent Malarias—Relationships with the Biology of Merozoites,” International Journal for Parasitology, Vol. 24, No. 6, 1994, pp. 981-986. doi:10.1016/0020-7519(94)90163-5

Copyright © 2021 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.